Systematic reviews to ascertain the safety of diabetes medications
about
Impact of clinical evidence communications and drug regulation changes concerning rosiglitazone on prescribing patterns of antidiabetic therapies.A 'reluctant' critical review: 'Manual for evidence-based clinical practice (2015)'.Interpreting the consequences of metformin accumulation in an emergency context: impact of the time frame on the blood metformin levels.FDA safety actions for antidiabetic drugs marketed in the US, 1980-2015.Nightmare and Abnormal Dreams: Rare Side Effects of Metformin?
P2860
Systematic reviews to ascertain the safety of diabetes medications
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Systematic reviews to ascertain the safety of diabetes medications
@ast
Systematic reviews to ascertain the safety of diabetes medications
@en
Systematic reviews to ascertain the safety of diabetes medications
@nl
type
label
Systematic reviews to ascertain the safety of diabetes medications
@ast
Systematic reviews to ascertain the safety of diabetes medications
@en
Systematic reviews to ascertain the safety of diabetes medications
@nl
prefLabel
Systematic reviews to ascertain the safety of diabetes medications
@ast
Systematic reviews to ascertain the safety of diabetes medications
@en
Systematic reviews to ascertain the safety of diabetes medications
@nl
P2093
P2860
P50
P1476
Systematic reviews to ascertain the safety of diabetes medications
@en
P2093
Aaron L. Leppin
Juan P. Brito
Oscar L. Morey-Vargas
P2860
P2888
P356
10.1007/S11892-014-0478-0
P407
P577
2014-04-01T00:00:00Z
P6179
1016186638